tiprankstipranks
Trending News
More News >
TG Therapeutics (TGTX)
NASDAQ:TGTX
Advertisement

TG Therapeutics (TGTX) Revenue

Compare
2,048 Followers

TG Therapeutics Revenue

TG Therapeutics had a revenue of 120.86M in the quarter ending Mar 31, 2025, with 11.71%. This bring the company's revenue in the last twelve months to 386.39M, Decreased 17.44%. In the fiscal year ending Dec 31, 2024, TG Therapeutics had annual revenue of 329.00M with 40.80% growth.
Revenue (ttm)
386.39M
Revenue Growth
33.54%
P/S Ratio
17.63
Revenue/Employee
$934,670
Employees
352
Market Cap
$5.80B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
329.00M95.34M+40.80%
Dec 31, 2023
233.66M230.88M+8,290.02%
Dec 31, 2022
2.79M-3.90M-58.36%
Dec 31, 2021
6.69M6.54M+4,300.66%
Dec 31, 2020
152.00K0.000.00%
Dec 31, 2019
152.00K0.000.00%
Dec 31, 2018
152.00K-381.00-0.25%
Dec 31, 2017
152.38K0.000.00%
Dec 31, 2016
152.38K
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis